1
|
Biswas S, Chakrabarti S, Chakraborty J,
Paul PC, Konar A and Das S: Childhood acute leukemia in West
Bengal, India with an emphasis on uncommon clinical features. Asian
Pac J Cancer Prev. 10:903–906. 2009.
|
2
|
Burke PW and Douer D: Acute lymphoblastic
leukemia in adolescents and young adults. Acta Haematol.
132:264–273. 2014. View Article : Google Scholar : PubMed/NCBI
|
3
|
Awan T, Iqbal Z, Aleem A, Sabir N, Absar
M, Rasool M, Tahir AH, Basit S, Khalid AM, Sabar MF, et al: Five
most common prognos-tically important fusion oncogenes are detected
in the majority of Pakistani pediatric acute lymphoblastic leukemia
patients and are strongly associated with disease biology and
treatment outcome. Asian Pac J Cancer Prev. 13:5469–5475. 2012.
View Article : Google Scholar
|
4
|
Shaikh MS, Adil SN, Shaikh MU and Khurshid
M: Frequency of chromosomal abnormalities in Pakistani adults with
acute lymphoblastic leukemia. Asian Pac J Cancer Prev.
15:9495–9498. 2014. View Article : Google Scholar : PubMed/NCBI
|
5
|
Zhao M, Yang M, Yang L, Yu Y, Xie M, Zhu
S, Kang R, Tang D, Jiang Z, Yuan W, et al: HMGB1 regulates
autophagy through increasing transcriptional activities of JNK and
ERK in human myeloid leukemia cells. BMB Rep. 44:601–606. 2011.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Yeoh AE, Tan D, Li CK, Hori H, Tse E and
Pui CH; Asian Oncology Summit 2013: Management of adult and
paediatric acute lymphoblastic leukaemia in Asia:
Resource-stratified guidelines from the Asian Oncology Summit 2013.
Lancet Oncol. 14:e508–e523. 2013. View Article : Google Scholar : PubMed/NCBI
|
7
|
Gaynon PS: Childhood acute lymphoblastic
leukaemia and relapse. Br J Haematol. 131:579–587. 2005. View Article : Google Scholar : PubMed/NCBI
|
8
|
Kulkarni KP and Marwaha RK: Outcomes of
children with relapsed acute lymphoblastic leukemia in India. Asian
Pac J Cancer Prev. 12:1101–1102. 2011.PubMed/NCBI
|
9
|
Tharnprisan P, Khiewyoo J, Sripraya P and
Wiangnon S: Relapse-free rate with childhood acute lymphoblastic
leukemia treated under the thai national protocol. Asian Pac J
Cancer Prev. 14:1127–1130. 2013. View Article : Google Scholar : PubMed/NCBI
|
10
|
Soheila K, Hamid A, Farid Z, Mostafa RT,
Nasrin DN, Syyed-Mohammad T and Vahide T: Comparison of univariate
and multivariate gene set analysis in acute lymphoblastic leukemia.
Asian Pac J Cancer Prev. 14:1629–1633. 2013. View Article : Google Scholar : PubMed/NCBI
|
11
|
Ross ME, Mahfouz R, Onciu M, Liu HC, Zhou
X, Song G, Shurtleff SA, Pounds S, Cheng C, Ma J, et al: Gene
expression profiling of pediatric acute myelogenous leukemia.
Blood. 104:3679–3687. 2004. View Article : Google Scholar : PubMed/NCBI
|
12
|
Unfried C, Burbach G, Korf HW and Von Gall
C: Melatonin receptor 1-dependent gene expression in the mouse pars
tuberalis as revealed by cDNA microarray analysis and in situ
hybridization. J Pineal Res. 48:148–156. 2010. View Article : Google Scholar : PubMed/NCBI
|
13
|
Wang Y, Zhang H, Li H and Miao X:
Second-generation sequencing supply an effective way to screen RNAi
targets in large scale for potential application in pest insect
control. PLoS One. 6:e186442011. View Article : Google Scholar : PubMed/NCBI
|
14
|
Bennett JM, Catovsky D, Daniel MT,
Flandrin G, Galton DA, Gralnick HR and Sultan C: Proposed revised
criteria for the classification of acute myeloid leukemia. A report
of the French-American-British Cooperative Group. Ann Intern Med.
103:620–625. 1985. View Article : Google Scholar : PubMed/NCBI
|
15
|
Cheson BD, Cassileth PA, Head DR, Schiffer
CA, Bennett JM, Bloomfield CD, Brunning R, Gale RP, Grever MR and
Keating MJ: Report of the National Cancer Institute-sponsored
workshop on definitions of diagnosis and response in acute myeloid
leukemia. J Clin Oncol. 8:813–819. 1990.PubMed/NCBI
|
16
|
't Hoen PA, Ariyurek Y, Thygesen HH,
Vreugdenhil E, Vossen RH, de Menezes RX, Boer JM, van Ommen GJ and
den Dunnen JT: Deep sequencing-based expression analysis shows
major advances in robustness, resolution and inter-lab portability
over five microarray platforms. Nucleic Acids Res. 36:e1412008.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Morrissy AS, Morin RD, Delaney A, Zeng T,
McDonald H, Jones S, Zhao Y, Hirst M and Marra MA: Next-generation
tag sequencing for cancer gene expression profiling. Genome Res.
19:1825–1835. 2009. View Article : Google Scholar : PubMed/NCBI
|
18
|
Li H, Ruan J and Durbin R: Mapping short
DNA sequencing reads and calling variants using mapping quality
scores. Genome Res. 18:1851–1858. 2008. View Article : Google Scholar : PubMed/NCBI
|
19
|
Mullighan CG: Genomic profiling of
B-progenitor acute lymphoblastic leukemia. Best Pract Res Clin
Haematol. 24:489–503. 2011. View Article : Google Scholar : PubMed/NCBI
|
20
|
Nordlund J, Kiialainen A, Karlberg O,
Berglund EC, Göransson-Kultima H, Sønderkær M, Nielsen KL,
Gustafsson MG, Behrendtz M, Forestier E, et al: Digital gene
expression profiling of primary acute lymphoblastic leukemia cells.
Leukemia. 26:1218–1227. 2012. View Article : Google Scholar :
|
21
|
Figueroa ME, Chen SC, Andersson AK,
Phillips LA, Li Y, Sotzen J, Kundu M, Downing JR, Melnick A and
Mullighan CG: Integrated genetic and epigenetic analysis of
childhood acute lymphoblastic leukemia. J Clin Invest.
123:3099–3111. 2013. View
Article : Google Scholar : PubMed/NCBI
|
22
|
Mullighan CG: Genome sequencing of
lymphoid malignancies. Blood. 122:3899–3907. 2013. View Article : Google Scholar : PubMed/NCBI
|
23
|
Iranparast S, Assarehzadegan MA, Heike Y,
Hossienzadeh M and Khodadadi A: Wilms' tumor gene (WT1) expression
correlates with vascular epithelial growth factor (VEGF) in newly
acute leukemia patients undergoing chemotherapy. Asian Pac J Cancer
Prev. 15:9217–9223. 2014. View Article : Google Scholar : PubMed/NCBI
|
24
|
Yang L, Han Y, Suarez Saiz F and Minden
MD: A tumor suppressor and oncogene: The WT1 story. Leukemia.
21:868–876. 2007.PubMed/NCBI
|
25
|
Bergmann L, Miething C, Maurer U, Brieger
J, Karakas T, Weidmann E and Hoelzer D: High levels of Wilms' tumor
gene (wt1) mRNA in acute myeloid leukemias are associated with a
worse long-term outcome. Blood. 90:1217–1225. 1997.PubMed/NCBI
|
26
|
Netinatsunthorn W, Hanprasertpong J,
Dechsukhum C, Leetanaporn R and Geater A: WT1 gene expression as a
prognostic marker in advanced serous epithelial ovarian carcinoma:
An immunohistochemical study. BMC Cancer. 6:902006. View Article : Google Scholar : PubMed/NCBI
|
27
|
Arteaga CL and Engelman JA: ERBB
receptors: From oncogene discovery to basic science to
mechanism-based cancer therapeutics. Cancer Cell. 25:282–303. 2014.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Hwang JA, Lee BB, Kim Y, Park SE, Heo K,
Hong SH, Kim YH, Han J, Shim YM, Lee YS and Kim DH: HOXA11
hypermethylation is associated with progression of non-small cell
lung cancer. Oncotarget. 4:2317–2325. 2013. View Article : Google Scholar : PubMed/NCBI
|
29
|
Koch J, Steinle A, Watzl C and Mandelboim
O: Activating natural cytotoxicity receptors of natural killer
cells in cancer and infection. Trends Immunol. 34:182–191. 2013.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Luo LP, Han B, Yu XP, Chen XY, Zhou J,
Chen W, Zhu YF, Peng XL, Zou Q and Li SY: Anti-metastasis activity
of black rice anthocyanins against breast cancer: Analyses using an
ErbB2 positive breast cancer cell line and tumoral xenograft model.
Asian Pac J Cancer Prev. 15:6219–6225. 2014. View Article : Google Scholar : PubMed/NCBI
|
31
|
Song Y and Zuo Y: Occurrence of HHIP gene
CpG island methylation in gastric cancer. Oncol Lett. 8:2340–2344.
2014.PubMed/NCBI
|